EU External Trade - Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, Amfepramone (INN), methadone (INN) and normethadone (INN); salts thereof

Extra-EU sourcing of Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, Amfepramone (INN), methadone (INN) and normethadone (INN); salts thereof is highly concentrated. 🇨🇭 Switzerland captures 53.9% of imports (€7.9M), followed by 🇮🇳 India (44.2%). With an HHI of 4856, this Concentrated market exposes the EU to supply dependency risks.

The EU exports Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, Amfepramone (INN), methadone (INN) and normethadone (INN); salts thereof to 7 extra-EU markets, reflecting solid diversification. 🇲🇽 Mexico remains the largest client (22.0%, €1.6M), followed by 🇲🇽 Mexico, 🇺🇦 Ukraine, 🇺🇸 United States.

Within the EU, the leading importers of Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, Amfepramone (INN), methadone (INN) and normethadone (INN); salts thereof are 🇮🇹 Italy, 🇩🇪 Germany, 🇫🇷 France. 🇮🇹 Italy accounts for 31.1% of EU imports.

In 2025, imports were falling sharply (-18.5%) and exports stable (3.0%) compared to the previous year.